Mary Lively, NP
Family · Dallas, TXNPI 1114261401
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.4% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Astellas Pharma US Inc at 35.5% of the total.
Across 102 payments — averaging $24.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$879
- AbbVie$405
- Organon$400
- Exeltis, USA Inc.$205
- Pfizer$93
- Shield Therapeutics Inc$88
- plus $406 from 11 others
What the payments were for
- Food & beverage$2,26491%
- Education$2129%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 33 | $879 |
| AbbVie | 17 | $405 |
| Organon | 17 | $400 |
| Exeltis, USA Inc. | 10 | $205 |
| Pfizer | 4 | $93 |
| Shield Therapeutics Inc | 4 | $88 |
| Bsn Medical Inc | 1 | $85 |
| Sage Therapeutics, LLC | 4 | $62 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Lupin Inc. | 2 | $42 |
| Merck | 1 | $31 |
| Ascend Therapeutics US, LLC | 2 | $30 |
| Hologic Sales And Service, LLC | 1 | $27 |
| Evofem Biosciences, Inc. | 1 | $24 |
| Coopersurgical, Inc. | 1 | $22 |
| Exact Sciences | 1 | $22 |
| Millicent US Inc | 1 | $13 |
How this compares
$2,476 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Dallas
- David WeirDallas$959K
- Sie ThomasDallas$197K
- Marcia HarrisDallas$156K
- Miles HortonDallas$72K
- Natasha SimmonsDallas$38K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.